Treatment of anemia in myelodysplastic syndrome with darbepoetin and granulocyte colony stimulating factor

Am J Hematol. 2007 Mar;82(3):245-6. doi: 10.1002/ajh.20725.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anemia / blood
  • Anemia / drug therapy*
  • Anemia / etiology
  • Darbepoetin alfa
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Erythropoietin / administration & dosage
  • Erythropoietin / analogs & derivatives*
  • Erythropoietin / therapeutic use
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Hematinics / administration & dosage
  • Hematinics / therapeutic use*
  • Humans
  • Male
  • Myelodysplastic Syndromes / blood*
  • Myelodysplastic Syndromes / complications
  • Recombinant Proteins
  • Treatment Outcome

Substances

  • Hematinics
  • Recombinant Proteins
  • Erythropoietin
  • Granulocyte Colony-Stimulating Factor
  • Darbepoetin alfa